5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Antifungal Activity of Plantago lanceolata and Sida ovata Leaf Extracts against Dermatomycotic Fungi

      research-article
      1 , , 2
      Evidence-based Complementary and Alternative Medicine : eCAM
      Hindawi

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Plantago lanceolata and Sida ovata have been used as medicinal plants for centuries to cure numerous diseases. This study aimed to evaluate antifungal activity of P. lanceolata and S. ovata leaf extracts against dermatomycotic fungi. Crude extracts from leaves of both plants were prepared using methanol and ethyl acetate. Phytochemical screening of both plants leaves was performed. Antifungal activity of crude extracts was evaluated against three dermatomycotic fungi ( Candida albicans, Malassezia furfur, and Malassezia globosa). In addition, minimum inhibitory concentration (MIC) of the extracts was determined by microbroth dilution method. Maximum inhibition zone of 32.00 ± 11.64 mm was exhibited when combined ethyl acetate extract of both plants was applied against M. globosa. Best effect of MIC was demonstrated by ethyl acetate extract against most tested dermatomycotic fungi. Average MIC of ethyl acetate and methanol extracts ranged as follows: (0.19 ± 0.00 to 0.65 ± 0.00 mg/mL and 0.19 ± 0.00 to 0.52 ± 0.22 mg/mL) and (0.65 ± 0.22 to 1.56 ± 0.00 mg/mL and 0.19 ± 0.00 to 0.52 ± 0.00 mg/mL), respectively. Their synergistic effect was better than the effect of individual plant leaf extract. Minimum fungicidal concentration (MFC) values varied across the fungal pathogens when extracts from both plants and their combinations were used. The findings from the current study support the traditional use of P. lanceolata and S. ovata against dermatomycotic fungal infections, which could potentially be exploited for the treatment of superficial infection in humans.

          Related collections

          Most cited references31

          • Record: found
          • Abstract: found
          • Article: not found

          Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances.

          The aim of broth and agar dilution methods is to determine the lowest concentration of the assayed antimicrobial agent (minimal inhibitory concentration, MIC) that, under defined test conditions, inhibits the visible growth of the bacterium being investigated. MIC values are used to determine susceptibilities of bacteria to drugs and also to evaluate the activity of new antimicrobial agents. Agar dilution involves the incorporation of different concentrations of the antimicrobial substance into a nutrient agar medium followed by the application of a standardized number of cells to the surface of the agar plate. For broth dilution, often determined in 96-well microtiter plate format, bacteria are inoculated into a liquid growth medium in the presence of different concentrations of an antimicrobial agent. Growth is assessed after incubation for a defined period of time (16-20 h) and the MIC value is read. This protocol applies only to aerobic bacteria and can be completed in 3 d.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Plant products as antimicrobial agents.

            The use of and search for drugs and dietary supplements derived from plants have accelerated in recent years. Ethnopharmacologists, botanists, microbiologists, and natural-products chemists are combing the Earth for phytochemicals and "leads" which could be developed for treatment of infectious diseases. While 25 to 50% of current pharmaceuticals are derived from plants, none are used as antimicrobials. Traditional healers have long used plants to prevent or cure infectious conditions; Western medicine is trying to duplicate their successes. Plants are rich in a wide variety of secondary metabolites, such as tannins, terpenoids, alkaloids, and flavonoids, which have been found in vitro to have antimicrobial properties. This review attempts to summarize the current status of botanical screening efforts, as well as in vivo studies of their effectiveness and toxicity. The structure and antimicrobial properties of phytochemicals are also addressed. Since many of these compounds are currently available as unregulated botanical preparations and their use by the public is increasing rapidly, clinicians need to consider the consequences of patients self-medicating with these preparations.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Recent advances in understanding the antibacterial properties of flavonoids.

              Antibiotic resistance is a major global problem and there is a pressing need to develop new therapeutic agents. Flavonoids are a family of plant-derived compounds with potentially exploitable activities, including direct antibacterial activity, synergism with antibiotics, and suppression of bacterial virulence. In this review, recent advances towards understanding these properties are described. Information is presented on the ten most potently antibacterial flavonoids as well as the five most synergistic flavonoid-antibiotic combinations tested in the last 6 years (identified from PubMed and ScienceDirect). Top of these respective lists are panduratin A, with minimum inhibitory concentrations (MICs) of 0.06-2.0 μg/mL against Staphylococcus aureus, and epicatechin gallate, which reduces oxacillin MICs as much as 512-fold. Research seeking to improve such activity and understand structure-activity relationships is discussed. Proposed mechanisms of action are also discussed. In addition to direct and synergistic activities, flavonoids inhibit a number of bacterial virulence factors, including quorum-sensing signal receptors, enzymes and toxins. Evidence of these molecular effects at the cellular level include in vitro inhibition of biofilm formation, inhibition of bacterial attachment to host ligands, and neutralisation of toxicity towards cultured human cells. In vivo evidence of disruption of bacterial pathogenesis includes demonstrated efficacy against Helicobacter pylori infection and S. aureus α-toxin intoxication. Copyright © 2011 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
                Bookmark

                Author and article information

                Contributors
                Journal
                Evid Based Complement Alternat Med
                Evid Based Complement Alternat Med
                ECAM
                Evidence-based Complementary and Alternative Medicine : eCAM
                Hindawi
                1741-427X
                1741-4288
                2023
                5 August 2023
                5 August 2023
                : 2023
                : 9957892
                Affiliations
                1Department of Environmental and Industrial Biotechnology, Institute of Biotechnology, University of Gondar, P.O. Box: 196, Gondar, Ethiopia
                2Department of Biotechnology, Institute of Biotechnology, University of Gondar, P.O. Box: 196, Gondar, Ethiopia
                Author notes

                Academic Editor: Emilio Lizarraga

                Author information
                https://orcid.org/0000-0003-1471-4330
                Article
                10.1155/2023/9957892
                10423090
                5a8af827-eb7e-4ed9-b0f0-b5c95293f2b7
                Copyright © 2023 Tamene Milkessa Jiru and Muluneh Getahun.

                This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 30 January 2023
                : 17 June 2023
                : 1 August 2023
                Categories
                Research Article

                Complementary & Alternative medicine
                Complementary & Alternative medicine

                Comments

                Comment on this article